These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1281362)
1. Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran. Oertli D; Hess P; Durig M; Laffer U; Fridrich R; Jaeger K; Kaufmann R; Harder F World J Surg; 1992; 16(5):980-4; discussion 984-5. PubMed ID: 1281362 [TBL] [Abstract][Full Text] [Related]
2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
3. [Prevention of thromboembolism in hip traumatology: low molecular weight heparin versus dextran]. Hess P; Oertli D; Dürig M; Laffer U; Fridrich R; Jäger K; Harder F Helv Chir Acta; 1992 May; 58(6):931-5. PubMed ID: 1379576 [TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group. Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709 [TBL] [Abstract][Full Text] [Related]
5. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742 [TBL] [Abstract][Full Text] [Related]
6. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Eriksson BI; Zachrisson BE; Teger-Nilsson AC; Risberg B Br J Surg; 1988 Nov; 75(11):1053-7. PubMed ID: 2463035 [TBL] [Abstract][Full Text] [Related]
7. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group. Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065 [TBL] [Abstract][Full Text] [Related]
8. [The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)]. Hubens A; Peeters R Acta Chir Belg; 1976 Jul; 75(4):402-15. PubMed ID: 797205 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement. Mätzsch T; Bergqvist D; Fredin H; Hedner U Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017 [TBL] [Abstract][Full Text] [Related]
10. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures. Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484 [TBL] [Abstract][Full Text] [Related]
12. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin. Hohl MK; Lüscher KP; Tichý J; Stiner M; Fridrich R; Gruber UF; Käser O Obstet Gynecol; 1980 Apr; 55(4):497-500. PubMed ID: 6154272 [TBL] [Abstract][Full Text] [Related]
13. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group. Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187 [TBL] [Abstract][Full Text] [Related]
14. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054 [TBL] [Abstract][Full Text] [Related]
15. The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients. Kim KK; Won Y; Won YY Yonsei Med J; 2016 Sep; 57(5):1209-13. PubMed ID: 27401653 [TBL] [Abstract][Full Text] [Related]
16. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran. Verstraete M Surg Gynecol Obstet; 1976 Dec; 143(6):981-5. PubMed ID: 996722 [TBL] [Abstract][Full Text] [Related]
17. Does dihydroergotamine potentiate the thromboprophylactic effect of dextran 70? A controlled prospective study in general and hip surgery. Bergqvist D; Lindblad B; Ljungström KG; Persson NH; Hallböök T Br J Surg; 1984 Jul; 71(7):516-21. PubMed ID: 6203596 [TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement. Mätzsch T; Bergqvist D; Fredin H; Hedner U Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053 [TBL] [Abstract][Full Text] [Related]
19. Dihydroergotamine and the thromboprophylactic effect of dextran 70 in emergency hip surgery. Rørbaek-Madsen M; Jakobsen BW; Pedersen J; Sørensen B Br J Surg; 1988 Apr; 75(4):364-5. PubMed ID: 2451968 [TBL] [Abstract][Full Text] [Related]
20. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting. Ennis RS J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]